Production (Stage)
Firefly Neuroscience, Inc.
AIFF
$3.46
$0.102.98%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 43.00K | 53.00K | 33.00K | 10.00K | 12.00K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 43.00K | 53.00K | 33.00K | 10.00K | 12.00K |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | 43.00K | 53.00K | 33.00K | 10.00K | 12.00K |
| SG&A Expenses | 1.80M | 2.18M | 3.42M | 919.00K | 814.00K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 2.11M | 2.62M | 4.30M | 1.27M | 1.10M |
| Operating Income | -2.07M | -2.56M | -4.27M | -1.26M | -1.09M |
| Income Before Tax | -12.93M | -3.78M | -4.29M | -1.26M | -1.12M |
| Income Tax Expenses | -- | 2.00K | -- | -- | -- |
| Earnings from Continuing Operations | -12.93M | -3.79M | -4.29M | -1.26M | -1.12M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -12.93M | -3.79M | -4.29M | -1.26M | -1.12M |
| EBIT | -2.07M | -2.56M | -4.27M | -1.26M | -1.09M |
| EBITDA | -2.05M | -2.56M | -4.26M | -1.26M | -- |
| EPS Basic | -1.74 | -0.43 | -0.61 | -0.03 | -0.22 |
| Normalized Basic EPS | -0.81 | -0.21 | -0.38 | -0.02 | -0.14 |
| EPS Diluted | -1.74 | -0.43 | -0.61 | -0.03 | -0.22 |
| Normalized Diluted EPS | -0.81 | -0.21 | -0.38 | -0.02 | -0.14 |
| Average Basic Shares Outstanding | 9.96M | 8.70M | 7.08M | 49.95M | 5.19M |
| Average Diluted Shares Outstanding | 9.96M | 8.70M | 7.08M | 49.95M | 5.19M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |